首页 > 最新文献

Clinical nutrition ESPEN最新文献

英文 中文
Dietary sodium and potassium intake and risk of diabetes in the Million Veteran Program 百万退伍军人计划中膳食钠和钾摄入量与糖尿病风险的关系。
IF 2.6 Q3 NUTRITION & DIETETICS Pub Date : 2026-01-03 DOI: 10.1016/j.clnesp.2025.102882
Xuan-Mai T. Nguyen , Yanping Li , April R. Williams , Neha Panigrahy , Mark S. Nyaeme , Kerry L. Ivey , Daniel D. Wang , Serena Houghton , Hasan Mahbub , Walter C. Willett , Frank B. Hu , John Michael Gaziano , Lawrence Phillips , Peter WF. Wilson , Kelly Cho , Luc Djousse , the VA Million Veteran Program

Background/objective

Studies show an association between elevated blood pressure, obesity, and insulin resistance with a higher risk of developing diabetes. As sodium is closely linked to elevated blood pressure and hypertension, and potassium is a counterbalancing nutrient to sodium, this study examines the association between intake of sodium, potassium, and sodium: potassium (Na:K) ratio and the incidence of diabetes.

Design setting and participants

Retrospective data analysis of dietary intake measured by a validated food frequency questionnaire in a prospective cohort of veterans participating in the Million Veteran Program (MVP) between 2011 and 2020, who were free of diabetes at baseline.

Main outcome measurement

The main outcome is clinically diagnosed diabetes defined by phenotyping algorithms applied to electronic health records.

Results

In this study of 198,049 veterans (mean age: 63.8 ± 13.1 years, 89 % male), 7260 were diagnosed with diabetes over a mean follow-up of 4.3 years. The mean sodium intake was 1218 mg/day. A higher sodium intake was associated with an 11 % higher rate of developing diabetes (hazard ratio, HR) comparing extreme quintiles: 1.11, 95 % CI: 1.03–1.20). The average daily potassium intake was 2589 mg and the highest quintile of potassium intake was associated with a 13 % lower rate of diabetes (HR: 0.87, 95 % CI: 0.81, 0.94) compared to the lowest quintile of potassium. Highest quintile of Na:K ratio was associated with a 21 % higher rate for diabetes (HR: 1.21, 95% CI: 1.12, 1.30). The pattern of associations between Na:K ratio and diabetes closely followed the pattern of dietary sodium intake and diabetes associations.

Conclusion

A higher sodium intake and a higher Na:K ratio were associated with a higher risk of diabetes in this large cohort of veterans. These findings may be applied in future work to identify personalized lifestyle and dietary supports to prevent and treat T2DM.
背景/目的:研究表明血压升高、肥胖和胰岛素抵抗与患糖尿病的高风险之间存在关联。由于钠与血压升高和高血压密切相关,而钾是钠的平衡营养素,本研究探讨了钠、钾和钠钾(Na:K)比的摄入与糖尿病发病率之间的关系。设计、设置和参与者:在2011年至2020年期间参加百万退伍军人计划(MVP)的退伍军人前瞻性队列中,通过有效的食物频率问卷测量饮食摄入量的回顾性数据分析,这些退伍军人在基线时无糖尿病。主要结果测量:主要结果是通过应用于电子健康记录的表型算法定义的临床诊断糖尿病。结果:在这项研究中,198,049名退伍军人(平均年龄:63.8±13.1岁,89%为男性),在平均4.3年的随访中,有7,260人被诊断患有糖尿病。平均钠摄入量为1218毫克/天。较高的钠摄入量与患糖尿病的几率增加11%相关(危险比,HR),比较极端五分位数:1.11,95% CI: 1.03-1.20)。Gs。平均每日钾摄入量为2589毫克,钾摄入量最高的五分位数与最低的五分位数相比,糖尿病发病率降低13% (HR: 0.87, 95% CI: 0.81, 0.94)。钠钾比最高的五分位数与糖尿病发病率高21%相关(HR:1.21, 95%CI: 1.12, 1.30)。钠钾比与糖尿病的关系模式与膳食钠摄入量与糖尿病的关系模式密切相关。结论:在这个庞大的退伍军人队列中,较高的钠摄入量和较高的钠钾比与较高的糖尿病风险相关。这些发现可能在未来的工作中应用,以确定个性化的生活方式和饮食支持,以预防和治疗2型糖尿病。
{"title":"Dietary sodium and potassium intake and risk of diabetes in the Million Veteran Program","authors":"Xuan-Mai T. Nguyen ,&nbsp;Yanping Li ,&nbsp;April R. Williams ,&nbsp;Neha Panigrahy ,&nbsp;Mark S. Nyaeme ,&nbsp;Kerry L. Ivey ,&nbsp;Daniel D. Wang ,&nbsp;Serena Houghton ,&nbsp;Hasan Mahbub ,&nbsp;Walter C. Willett ,&nbsp;Frank B. Hu ,&nbsp;John Michael Gaziano ,&nbsp;Lawrence Phillips ,&nbsp;Peter WF. Wilson ,&nbsp;Kelly Cho ,&nbsp;Luc Djousse ,&nbsp;the VA Million Veteran Program","doi":"10.1016/j.clnesp.2025.102882","DOIUrl":"10.1016/j.clnesp.2025.102882","url":null,"abstract":"<div><h3>Background/objective</h3><div>Studies show an association between elevated blood pressure, obesity, and insulin resistance with a higher risk of developing diabetes. As sodium is closely linked to elevated blood pressure and hypertension, and potassium is a counterbalancing nutrient to sodium, this study examines the association between intake of sodium, potassium, and sodium: potassium (Na:K) ratio and the incidence of diabetes.</div></div><div><h3>Design setting and participants</h3><div>Retrospective data analysis of dietary intake measured by a validated food frequency questionnaire in a prospective cohort of veterans participating in the Million Veteran Program (MVP) between 2011 and 2020, who were free of diabetes at baseline.</div></div><div><h3>Main outcome measurement</h3><div>The main outcome is clinically diagnosed diabetes defined by phenotyping algorithms applied to electronic health records.</div></div><div><h3>Results</h3><div>In this study of 198,049 veterans (mean age: 63.8 ± 13.1 years, 89 % male), 7260 were diagnosed with diabetes over a mean follow-up of 4.3 years. The mean sodium intake was 1218 mg/day. A higher sodium intake was associated with an 11 % higher rate of developing diabetes (hazard ratio, HR) comparing extreme quintiles: 1.11, 95 % CI: 1.03–1.20). The average daily potassium intake was 2589 mg and the highest quintile of potassium intake was associated with a 13 % lower rate of diabetes (HR: 0.87, 95 % CI: 0.81, 0.94) compared to the lowest quintile of potassium. Highest quintile of Na:K ratio was associated with a 21 % higher rate for diabetes (HR: 1.21, 95% CI: 1.12, 1.30). The pattern of associations between Na:K ratio and diabetes closely followed the pattern of dietary sodium intake and diabetes associations.</div></div><div><h3>Conclusion</h3><div>A higher sodium intake and a higher Na:K ratio were associated with a higher risk of diabetes in this large cohort of veterans. These findings may be applied in future work to identify personalized lifestyle and dietary supports to prevent and treat T2DM.</div></div>","PeriodicalId":10352,"journal":{"name":"Clinical nutrition ESPEN","volume":"71 ","pages":"Article 102882"},"PeriodicalIF":2.6,"publicationDate":"2026-01-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145899280","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Energy, carbohydrates and fats in clinical sports nutrition 临床运动营养中的能量、碳水化合物和脂肪。
IF 2.6 Q3 NUTRITION & DIETETICS Pub Date : 2026-01-03 DOI: 10.1016/j.clnesp.2025.102900
Ana Karin Kozjek Schwietert , Krištof Knap , Gašper Tonin , Nada Rotovnik Kozjek , Michael Gleeson
Energy metabolism plays a central role in supporting physical activity and athletic performance. In almost all forms of exercise different metabolic pathways and energy systems are used concurrently, with their relative contributions depending on exercise intensity, duration, fuel availability, environment, and physiological adaptations. Carbohydrates and fats both serve as the primary energy sources, with fat dominating during rest and low-intensity exercise, and carbohydrates becoming a preferential fuel at moderate to high exercise intensities. With longer duration of exercise, muscle energy stores become gradually depleted and blood glucose and adipose tissue derived fatty acids become increasingly important sources of energy. Prolonged exercise performance can be enhanced with exogenous carbohydrate supplementation in form of drinks, gels or snacks. Maintaining adequate energy and carbohydrate availability is crucial to support training and recovery and to prevent negative health consequences. While low-carbohydrate, high-fat diets may increase fat oxidation, they often impair performance at higher intensities. Individualised and periodised nutritional strategies that tailor energy and macronutrient intakes to meet the daily requirements of an active individual are essential to optimise health, support adaptations to exercise, and achieve training goals.
能量代谢在支持身体活动和运动表现方面起着核心作用。在几乎所有形式的运动中,不同的代谢途径和能量系统同时被使用,它们的相对贡献取决于运动强度、持续时间、燃料可用性、环境和生理适应。碳水化合物和脂肪都是主要的能量来源,在休息和低强度运动时以脂肪为主,在中高强度运动时碳水化合物成为首选的能量来源。随着运动时间的延长,肌肉能量储备逐渐消耗,血糖和脂肪组织来源的脂肪酸成为越来越重要的能量来源。长时间的运动表现可以通过饮料、凝胶或零食形式的外源性碳水化合物补充来增强。保持充足的能量和碳水化合物供应对于支持训练和恢复以及防止对健康产生负面影响至关重要。虽然低碳水化合物、高脂肪的饮食可能会增加脂肪氧化,但它们往往会影响高强度运动的表现。个性化和周期性的营养策略,定制能量和大量营养素的摄入量,以满足一个活跃的个人的日常需求,是优化健康,支持适应运动和实现训练目标的必要条件。
{"title":"Energy, carbohydrates and fats in clinical sports nutrition","authors":"Ana Karin Kozjek Schwietert ,&nbsp;Krištof Knap ,&nbsp;Gašper Tonin ,&nbsp;Nada Rotovnik Kozjek ,&nbsp;Michael Gleeson","doi":"10.1016/j.clnesp.2025.102900","DOIUrl":"10.1016/j.clnesp.2025.102900","url":null,"abstract":"<div><div>Energy metabolism plays a central role in supporting physical activity and athletic performance. In almost all forms of exercise different metabolic pathways and energy systems are used concurrently, with their relative contributions depending on exercise intensity, duration, fuel availability, environment, and physiological adaptations. Carbohydrates and fats both serve as the primary energy sources, with fat dominating during rest and low-intensity exercise, and carbohydrates becoming a preferential fuel at moderate to high exercise intensities. With longer duration of exercise, muscle energy stores become gradually depleted and blood glucose and adipose tissue derived fatty acids become increasingly important sources of energy. Prolonged exercise performance can be enhanced with exogenous carbohydrate supplementation in form of drinks, gels or snacks. Maintaining adequate energy and carbohydrate availability is crucial to support training and recovery and to prevent negative health consequences. While low-carbohydrate, high-fat diets may increase fat oxidation, they often impair performance at higher intensities. Individualised and periodised nutritional strategies that tailor energy and macronutrient intakes to meet the daily requirements of an active individual are essential to optimise health, support adaptations to exercise, and achieve training goals.</div></div>","PeriodicalId":10352,"journal":{"name":"Clinical nutrition ESPEN","volume":"71 ","pages":"Article 102900"},"PeriodicalIF":2.6,"publicationDate":"2026-01-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145905619","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Poor appetite and growth differentiation factor-15 as predictors of insufficient energy and protein intake during and after hospitalization in older adults with acute medical illness: Exploratory analysis of a randomized controlled trial 食欲不振和生长分化因子-15作为急性内科疾病老年人住院期间和住院后能量和蛋白质摄入不足的预测因素:一项随机对照试验的探索性分析
IF 2.6 Q3 NUTRITION & DIETETICS Pub Date : 2026-01-02 DOI: 10.1016/j.clnesp.2025.102895
Olivia Bornæs , Rikke Lundsgaard Nielsen , Morten Baltzer Houlind , Thomas Kallemose , Baker Nawfal Jawad , David Peick Sonne , Ingrid Poulsen , Aino Leegaard Andersen , Mette Merete Pedersen

Background & aims

Poor appetite is a key contributor to malnutrition in older adults, partly due to reduced dietary intake. While nutritional deficits are well recognized, the biological mechanisms driving poor appetite remain incompletely understood. Growth Differentiation Factor-15 (GDF-15) and the Simplified Nutritional Appetite Questionnaire (SNAQ) may help identify patients at risk of insufficient intake. This study examines the association between GDF-15 and insufficient energy and protein intake and evaluates the predictive performance of GDF-15 and SNAQ - individually and in combination - to identify insufficient energy and protein intake (<75 % and <100 % of estimated requirements, respectively) in acutely admitted older adults.

Methods

This exploratory study included 130 older adults (≥65 years) with or at risk of malnutrition, admitted for acute medical illness and assessed at baseline, and 8 and 16 weeks post-discharge (FW8 and FW16). GDF-15 plasma concentrations were measured from blood samples, SNAQ scores from validated questionnaire, and energy and protein intake were evaluated through 3-day dietary records. Associations were analyzed using regression models and predictive performance was evaluated using Receiver Operating Characteristic analysis.

Results

A doubling of GDF-15 showed a 6.73 % (−13.98–0.51) and 5.07 % (−12.18–2.05) lower baseline energy and protein intake, and results decreased after discharge. Using predefined cut-offs of ≥1500 pg/mL for GDF-15 and ≤14 for SNAQ, the highest positive predictive values (PPVs) were 86 (95 % CI: 0.83–0.89) and 90 (0.79–1.00) at baseline and FW8 for insufficient protein intake, respectively, with corresponding sensitivities of 84 (0.75–0.92) and 60 (0.44–0.74). For estimated cut-offs of 2095 pg/mL for GDF-15 at baseline and 18.5 for SNAQ at FW8, the highest PPVs were 89 (0.84–0.94) and 87 (0.86–0.87), with sensitivities of 73 (0.62–0.84) and 99 (0.96–1.00), both for insufficient protein intake, respectively. Combining GDF-15 and SNAQ yielded improved PPVs at the expense of reduced sensitivity in most models. All results were non-significant.

Conclusion

Higher GDF-15 levels showed a non-significant trend toward lower baseline energy and protein intake. GDF-15 and SNAQ offer limited ability to identify insufficient energy and protein intake, based on predictive performance. These exploratory findings should therefore be interpreted cautiously. Larger studies are needed to validate and further refine the use of GDF-15 and SNAQ in clinical settings.
背景与目的:食欲不振是老年人营养不良的一个关键因素,部分原因是饮食摄入量减少。虽然营养缺乏是公认的,但导致食欲不振的生物学机制仍然不完全清楚。生长分化因子-15 (GDF-15)和简化营养食欲问卷(SNAQ)可能有助于识别有摄入不足风险的患者。本研究考察了GDF-15与能量和蛋白质摄入不足之间的关系,并评估了GDF-15和SNAQ的预测性能(单独或联合),以确定能量和蛋白质摄入不足(方法:本探索性研究包括130名患有或有营养不良风险的老年人(≥65岁),因急性医学疾病入院并在基线时进行评估,出院后8周和16周(FW8和FW16)。从血液样本中测量GDF-15血浆浓度,从有效问卷中测量SNAQ评分,并通过3天的饮食记录评估能量和蛋白质摄入量。使用回归模型分析关联,使用受试者工作特征分析评估预测性能。结果:GDF-15增加一倍,基线能量和蛋白质摄入量分别降低6.73%(-13.98 - 0.51)和5.07%(-12.18 - 2.05),出院后降低。使用GDF-15≥1500 pg/mL和SNAQ≤14的预定义截断值,基线时最高阳性预测值(ppv)分别为86 (95% CI: 0.83-0.89)和90(0.79-1.00),蛋白质摄入不足时最高阳性预测值(ppv)为FW8,相应的敏感性为84(0.75-0.92)和60(0.44-0.74)。基线时GDF-15的估计截断值为2095 pg/mL, FW8时SNAQ的估计截断值为18.5 pg/mL,最高ppv分别为89(0.84-0.94)和87(0.86-0.87),敏感性分别为73(0.62-0.84)和99(0.96-1.00),两者均为蛋白质摄入不足。在大多数模型中,GDF-15和SNAQ的结合以降低灵敏度为代价提高了ppv。所有结果均无显著性。结论:较高的GDF-15水平对降低基线能量和蛋白质摄入量没有显著的趋势。基于预测性能,GDF-15和SNAQ识别能量和蛋白质摄入不足的能力有限。因此,这些探索性发现应谨慎解释。需要更大规模的研究来验证和进一步完善临床环境中GDF-15和SNAQ的使用。
{"title":"Poor appetite and growth differentiation factor-15 as predictors of insufficient energy and protein intake during and after hospitalization in older adults with acute medical illness: Exploratory analysis of a randomized controlled trial","authors":"Olivia Bornæs ,&nbsp;Rikke Lundsgaard Nielsen ,&nbsp;Morten Baltzer Houlind ,&nbsp;Thomas Kallemose ,&nbsp;Baker Nawfal Jawad ,&nbsp;David Peick Sonne ,&nbsp;Ingrid Poulsen ,&nbsp;Aino Leegaard Andersen ,&nbsp;Mette Merete Pedersen","doi":"10.1016/j.clnesp.2025.102895","DOIUrl":"10.1016/j.clnesp.2025.102895","url":null,"abstract":"<div><h3>Background &amp; aims</h3><div>Poor appetite is a key contributor to malnutrition in older adults, partly due to reduced dietary intake. While nutritional deficits are well recognized, the biological mechanisms driving poor appetite remain incompletely understood. Growth Differentiation Factor-15 (GDF-15) and the Simplified Nutritional Appetite Questionnaire (SNAQ) may help identify patients at risk of insufficient intake. This study examines the association between GDF-15 and insufficient energy and protein intake and evaluates the predictive performance of GDF-15 and SNAQ - individually and in combination - to identify insufficient energy and protein intake (&lt;75 % and &lt;100 % of estimated requirements, respectively) in acutely admitted older adults.</div></div><div><h3>Methods</h3><div>This exploratory study included 130 older adults (≥65 years) with or at risk of malnutrition, admitted for acute medical illness and assessed at baseline, and 8 and 16 weeks post-discharge (FW8 and FW16). GDF-15 plasma concentrations were measured from blood samples, SNAQ scores from validated questionnaire, and energy and protein intake were evaluated through 3-day dietary records. Associations were analyzed using regression models and predictive performance was evaluated using Receiver Operating Characteristic analysis.</div></div><div><h3>Results</h3><div>A doubling of GDF-15 showed a 6.73 % (−13.98–0.51) and 5.07 % (−12.18–2.05) lower baseline energy and protein intake, and results decreased after discharge. Using predefined cut-offs of ≥1500 pg/mL for GDF-15 and ≤14 for SNAQ, the highest positive predictive values (PPVs) were 86 (95 % CI: 0.83–0.89) and 90 (0.79–1.00) at baseline and FW8 for insufficient protein intake, respectively, with corresponding sensitivities of 84 (0.75–0.92) and 60 (0.44–0.74). For estimated cut-offs of 2095 pg/mL for GDF-15 at baseline and 18.5 for SNAQ at FW8, the highest PPVs were 89 (0.84–0.94) and 87 (0.86–0.87), with sensitivities of 73 (0.62–0.84) and 99 (0.96–1.00), both for insufficient protein intake, respectively. Combining GDF-15 and SNAQ yielded improved PPVs at the expense of reduced sensitivity in most models. All results were non-significant.</div></div><div><h3>Conclusion</h3><div>Higher GDF-15 levels showed a non-significant trend toward lower baseline energy and protein intake. GDF-15 and SNAQ offer limited ability to identify insufficient energy and protein intake, based on predictive performance. These exploratory findings should therefore be interpreted cautiously. Larger studies are needed to validate and further refine the use of GDF-15 and SNAQ in clinical settings.</div></div>","PeriodicalId":10352,"journal":{"name":"Clinical nutrition ESPEN","volume":"71 ","pages":"Article 102895"},"PeriodicalIF":2.6,"publicationDate":"2026-01-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145899326","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Survival of patients after a hip fracture: Influence of previous nutritional status on outcomes 髋部骨折后患者的生存:既往营养状况对预后的影响
IF 2.6 Q3 NUTRITION & DIETETICS Pub Date : 2026-01-02 DOI: 10.1016/j.clnesp.2025.102897
M.C. Cervera-Díaz , J.J. López-Gómez , H.J. Aguado-Hernández , V. García-Virto , D. Rico-Bargues , D.A. De Luis-Román

Background

Sarcopenia is a highly prevalent condition in patients with hip fracture; this condition can be related with prognosis. The main aim of this study was to investigate the survival rate of hip fracture inpatients and factors associated with mortality after six months and five years of the fracture event.

Methods

A real-world prospective study was carried out on 186 patients aged 75 years and older admitted after hip fracture, which were assessed within 48 h previous to surgical intervention. Hospitalized patients were able to walk before the fracture and showed no signs of cognitive impairment or chronic degenerative pathologies that posed a high risk of mortality. Integral Geriatric Assessment (IGA) was carried out at admission, at discharge, and after one, three and six months. Handgrip strength (HGS) was tested and lean tissue estimated through Bioelectrical Impedanciometry Analysis (BIA). Follow-up of all patients was carried out in order to record survival status or decease date. Mini-Nutritional Assessment (MNA) and European Working Group on Sarcopenia in Older People (EWGSOP2) criteria were recorded to assess disease-related malnutrition (DRM) and sarcopenia.

Results

Age was 86.2 (75–104) years, with 81.7 % of women. Sarcopenia prevalence was of 59,1 % (with 76.9 % of patients showing low HGS and 73,7 % low estimated lean soft tissue. DRM was established in 81.2 % of patients, with 48,9 % of them showing both malnutrition and sarcopenia. Mortality within the first six months was 12.3 % increasing to 14,5 % and 51,6 % after one- and five-years follow-up respectively.The multivariate analyses identified the following significant factors associated with mortality across all subgroups: low handgrip (OR 3.61, 95 % CI (1.55–8.44; p < 0.01), age >85 years (OR 2.44; CI 1.24–4.81; p = 0.01), Barthel index at admission <60 (OR 0.47, 95%CI 0.22–0.99; p = 0.049, and BMI <22 kg/m2 (OR 0.26; 95 % CI: 0.12–0.59; p < 0.01))

Conclusions

Over half of hip fracture patients exhibit sarcopenia, with 81 % experiencing DRM, and nearly 50 % presenting both conditions simultaneously. Mortality at six months and five years is associated with sarcopenia, poorer nutritional status at the time of hospitalization, and a lower prefracture functional status.
背景:骨骼肌减少症在髋部骨折患者中非常普遍;这种情况可能与预后有关。本研究的主要目的是调查髋部骨折住院患者的生存率以及骨折事件发生6个月和5年后死亡率的相关因素。方法:对186例75岁及以上髋部骨折患者进行现实世界前瞻性研究,并在手术干预前48小时内进行评估。住院患者在骨折前能够行走,没有表现出认知障碍或慢性退行性疾病的迹象,这些症状会带来很高的死亡率。在入院时、出院时、1个月、3个月和6个月后进行综合老年评估(IGA)。通过生物电阻抗分析(BIA)测定了手握力(HGS)和瘦组织(lean tissue)。对所有患者进行随访,记录患者的生存状况或死亡日期。记录迷你营养评估(MNA)和欧洲老年人肌肉减少症工作组(EWGSOP2)标准,以评估疾病相关营养不良(DRM)和肌肉减少症。结果:年龄86.2(75 ~ 104)岁,女性占81.7%。骨骼肌减少症患病率为59.1%(其中76.9%的患者表现为低HGS, 73.7%的患者表现为低估计的瘦软组织。81.2%的患者存在DRM,其中48.9%的患者同时表现为营养不良和肌肉减少症。前6个月的死亡率为12.3%,在1年和5年随访后分别增加到14.5%和51.6%。多因素分析确定了以下与所有亚组死亡率相关的重要因素:低握力(OR 3.61, 95%CI (1.55-8.44; p= 85)年(OR 2.44; CI 1.24-4.81; p=0.01),入院时Barthel指数< 60 (OR 0.47, 95%CI 0.22-0.99; p=0.049), BMI < 22 kg/m2 (OR 0.26; 95%CI: 0.12-0.59; p=0.049)
{"title":"Survival of patients after a hip fracture: Influence of previous nutritional status on outcomes","authors":"M.C. Cervera-Díaz ,&nbsp;J.J. López-Gómez ,&nbsp;H.J. Aguado-Hernández ,&nbsp;V. García-Virto ,&nbsp;D. Rico-Bargues ,&nbsp;D.A. De Luis-Román","doi":"10.1016/j.clnesp.2025.102897","DOIUrl":"10.1016/j.clnesp.2025.102897","url":null,"abstract":"<div><h3>Background</h3><div>Sarcopenia is a highly prevalent condition in patients with hip fracture; this condition can be related with prognosis. The main aim of this study was to investigate the survival rate of hip fracture inpatients and factors associated with mortality after six months and five years of the fracture event.</div></div><div><h3>Methods</h3><div>A real-world prospective study was carried out on 186 patients aged 75 years and older admitted after hip fracture, which were assessed within 48 h previous to surgical intervention. Hospitalized patients were able to walk before the fracture and showed no signs of cognitive impairment or chronic degenerative pathologies that posed a high risk of mortality. Integral Geriatric Assessment (IGA) was carried out at admission, at discharge, and after one, three and six months. Handgrip strength (HGS) was tested and lean tissue estimated through Bioelectrical Impedanciometry Analysis (BIA). Follow-up of all patients was carried out in order to record survival status or decease date. Mini-Nutritional Assessment (MNA) and European Working Group on Sarcopenia in Older People (EWGSOP2) criteria were recorded to assess disease-related malnutrition (DRM) and sarcopenia.</div></div><div><h3>Results</h3><div>Age was 86.2 (75–104) years, with 81.7 % of women. Sarcopenia prevalence was of 59,1 % (with 76.9 % of patients showing low HGS and 73,7 % low estimated lean soft tissue. DRM was established in 81.2 % of patients, with 48,9 % of them showing both malnutrition and sarcopenia. Mortality within the first six months was 12.3 % increasing to 14,5 % and 51,6 % after one- and five-years follow-up respectively.The multivariate analyses identified the following significant factors associated with mortality across all subgroups: low handgrip (OR 3.61, 95 % CI (1.55–8.44; <em>p</em> &lt; 0.01), age &gt;85 years (OR 2.44; CI 1.24–4.81; <em>p</em> = 0.01), Barthel index at admission &lt;60 (OR 0.47, 95%CI 0.22–0.99; <em>p</em> = 0.049, and BMI &lt;22 kg/m<sup>2</sup> (OR 0.26; 95 % CI: 0.12–0.59; <em>p</em> &lt; 0.01))</div></div><div><h3>Conclusions</h3><div>Over half of hip fracture patients exhibit sarcopenia, with 81 % experiencing DRM, and nearly 50 % presenting both conditions simultaneously. Mortality at six months and five years is associated with sarcopenia, poorer nutritional status at the time of hospitalization, and a lower prefracture functional status.</div></div>","PeriodicalId":10352,"journal":{"name":"Clinical nutrition ESPEN","volume":"71 ","pages":"Article 102897"},"PeriodicalIF":2.6,"publicationDate":"2026-01-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145899286","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association of nutrition impact symptoms with dietary intake among patients with advanced cancer referred to palliative care 姑息治疗晚期癌症患者营养影响症状与饮食摄入的关系
IF 2.6 Q3 NUTRITION & DIETETICS Pub Date : 2025-12-31 DOI: 10.1016/j.clnesp.2025.102894
Koji Amano , Vickie E. Baracos , Saori Koshimoto , Tatsuma Sakaguchi , Sayaka Arakawa , Naoharu Mori

Background & aims

Considering that cachexia-related symptoms interfere with dietary intake and compromise nutritional status in advanced cancer patients, these symptoms are classified as nutrition impact symptoms (NISs). However, the extent to which each NIS interferes with dietary intake remains unclear. Therefore, we examined the association between each NIS and dietary intake, considering the impact of an NIS cluster, and investigated the ability of each NIS to predict reduced dietary intake.

Methods

This is a secondary analysis using two datasets obtained from two surveys using a self-reported questionnaire conducted among advanced cancer patients referred to palliative care in multiple cancer hospitals. Participants evaluated 19 NISs (e.g., lack of appetite, early satiety, nausea, abnormal taste, and fatigue) and their dietary intake using a numerical rating scale (NRS) and the Ingesta-Verbal/Visual Analog Scale (IVVAS), respectively. To assess associations between each NIS and dietary intake, multivariate logistic regression analysis was performed adjusting for potential confounders, including four or more NISs with an NRS score of 4 or more as an NIS cluster. Values of the area under the curve (AUC) were also calculated for predicting a median IVVAS score or lower.

Results

Data were obtained from 328 participants in Survey 1 and 220 participants in Survey 2. Lack of appetite, early satiety, nausea, vomiting, abnormal taste, and fatigue were significantly associated with poor dietary intake (odds ratio [OR] 0.73, 95 % confidence interval [CI] 0.66–0.81; OR 0.84, 95 % CI 0.77–0.92; OR 0.80, 95 % CI 0.72–0.89; OR 0.80, 95 % CI 0.71–0.91; OR 0.91, 95 % CI 0.84–1.00; OR 0.90, 95 % CI 0.81–0.99, respectively). However, no significant association was observed for the other 13 NISs. All AUC values were greater than 0.750 for the 19 NISs. The highest AUC values were observed for lack of appetite, early satiety, and nausea (0.831, 95 % CI 0.797–0.866; 0.810, 95 % CI 0.773–0.848; 0.801, 95 % CI 0.764–0.838, respectively).

Conclusions

Lack of appetite, early satiety, nausea, vomiting, abnormal taste, and fatigue were significantly associated with dietary intake independently of the influence of other symptoms and other confounders. Furthermore, lack of appetite, early satiety, and nausea were good predictors for reduced dietary intake.
背景与目的:考虑到恶病质相关症状对晚期癌症患者饮食摄入的干扰和营养状况的损害,这些症状被归类为营养影响症状(NISs)。然而,每种NIS对饮食摄入的干扰程度仍不清楚。因此,考虑到NIS集群的影响,我们研究了每个NIS与饮食摄入量之间的关系,并调查了每个NIS预测饮食摄入量减少的能力。方法:这是一个二次分析,使用两个数据集,从两个调查中获得,使用自我报告的问卷,在多家癌症医院转诊姑息治疗的晚期癌症患者中进行。参与者分别使用数字评定量表(NRS)和摄入-言语/视觉模拟量表(IVVAS)评估19种NISs(如食欲不振、早饱、恶心、味觉异常和疲劳)及其饮食摄入量。为了评估每个NIS与饮食摄入之间的关联,进行了多变量logistic回归分析,调整了潜在的混杂因素,包括4个或更多的NISs, NRS评分为4分或以上作为NIS集群。还计算曲线下面积(AUC)值,以预测IVVAS中位评分或更低。结果:从调查1的328名参与者和调查2的220名参与者中获得数据。食欲不振、早饱、恶心、呕吐、味觉异常和疲劳与不良饮食摄入显著相关(比值比[OR] 0.73, 95%可信区间[CI] 0.66-0.81; OR 0.84, 95% CI 0.77-0.92; OR 0.80, 95% CI 0.72-0.89; OR 0.80, 95% CI 0.71-0.91; OR 0.91, 95% CI 0.84-1.00; OR 0.90, 95% CI 0.81-0.99)。然而,在其他13种NISs中没有观察到显著的关联。19个NISs的AUC值均大于0.750。AUC值最高的是食欲不振、早饱和恶心(分别为0.831,95% CI 0.797-0.866; 0.810, 95% CI 0.773-0.848; 0.801, 95% CI 0.764-0.838)。结论:食欲不振、早饱、恶心、呕吐、味觉异常和疲劳与饮食摄入显著相关,独立于其他症状和其他混杂因素的影响。此外,食欲不振、早饱和恶心是饮食摄入量减少的良好预测指标。
{"title":"Association of nutrition impact symptoms with dietary intake among patients with advanced cancer referred to palliative care","authors":"Koji Amano ,&nbsp;Vickie E. Baracos ,&nbsp;Saori Koshimoto ,&nbsp;Tatsuma Sakaguchi ,&nbsp;Sayaka Arakawa ,&nbsp;Naoharu Mori","doi":"10.1016/j.clnesp.2025.102894","DOIUrl":"10.1016/j.clnesp.2025.102894","url":null,"abstract":"<div><h3>Background &amp; aims</h3><div>Considering that cachexia-related symptoms interfere with dietary intake and compromise nutritional status in advanced cancer patients, these symptoms are classified as nutrition impact symptoms (NISs). However, the extent to which each NIS interferes with dietary intake remains unclear. Therefore, we examined the association between each NIS and dietary intake, considering the impact of an NIS cluster, and investigated the ability of each NIS to predict reduced dietary intake.</div></div><div><h3>Methods</h3><div>This is a secondary analysis using two datasets obtained from two surveys using a self-reported questionnaire conducted among advanced cancer patients referred to palliative care in multiple cancer hospitals. Participants evaluated 19 NISs (e.g., lack of appetite, early satiety, nausea, abnormal taste, and fatigue) and their dietary intake using a numerical rating scale (NRS) and the Ingesta-Verbal/Visual Analog Scale (IVVAS), respectively. To assess associations between each NIS and dietary intake, multivariate logistic regression analysis was performed adjusting for potential confounders, including four or more NISs with an NRS score of 4 or more as an NIS cluster. Values of the area under the curve (AUC) were also calculated for predicting a median IVVAS score or lower.</div></div><div><h3>Results</h3><div>Data were obtained from 328 participants in Survey 1 and 220 participants in Survey 2. Lack of appetite, early satiety, nausea, vomiting, abnormal taste, and fatigue were significantly associated with poor dietary intake (odds ratio [OR] 0.73, 95 % confidence interval [CI] 0.66–0.81; OR 0.84, 95 % CI 0.77–0.92; OR 0.80, 95 % CI 0.72–0.89; OR 0.80, 95 % CI 0.71–0.91; OR 0.91, 95 % CI 0.84–1.00; OR 0.90, 95 % CI 0.81–0.99, respectively). However, no significant association was observed for the other 13 NISs. All AUC values were greater than 0.750 for the 19 NISs. The highest AUC values were observed for lack of appetite, early satiety, and nausea (0.831, 95 % CI 0.797–0.866; 0.810, 95 % CI 0.773–0.848; 0.801, 95 % CI 0.764–0.838, respectively).</div></div><div><h3>Conclusions</h3><div>Lack of appetite, early satiety, nausea, vomiting, abnormal taste, and fatigue were significantly associated with dietary intake independently of the influence of other symptoms and other confounders. Furthermore, lack of appetite, early satiety, and nausea were good predictors for reduced dietary intake.</div></div>","PeriodicalId":10352,"journal":{"name":"Clinical nutrition ESPEN","volume":"71 ","pages":"Article 102894"},"PeriodicalIF":2.6,"publicationDate":"2025-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145892199","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Economic consequences when enteral tube feeding intolerance causes unplanned discontinuation in hospitalized older patients with gastroesophageal reflux disease 住院老年胃食管反流病患者肠内管喂养不耐受导致计划外停药的经济后果。
IF 2.6 Q3 NUTRITION & DIETETICS Pub Date : 2025-12-30 DOI: 10.1016/j.clnesp.2025.102892
Yukikazu Kamada , Kanako Kawano , Akina Iguchi , Noriko Tominaga , Chisato Okamoto , Masatoshi Inoue , Ataru Igarashi , Masafumi Kitakaze

Background & aims

Enteral tube feeding intolerance (ETFI) is a common complication in older patients with gastroesophageal reflux disease (GERD), often leading to unplanned discontinuation of nutritional support. While the clinical consequences of ETFI are well-documented, its economic impact on hospital operations remains unclear. This study aimed to evaluate the financial consequences of ETFI-related discontinuation of enteral nutrition in hospitalized older patients with GERD, focusing on changes in medical resource allocation and hospital revenue under Japan's hybrid reimbursement system.

Methods

A retrospective observational study was conducted using patient-level data from a long-term care ward in Japan between April 2018 and March 2021. Patients who initiated enteral tube feeding were categorized based on whether enteral feeding was discontinued due to intolerance. Medical claims data were analyzed to calculate fee-for-service (FFS) and fixed payment system (FPS) charges, unreimbursed medical charges (i.e., revenue loss under FPS), and inpatient living care expenses. Hospital loss simulations were performed based on discontinuation rates and patient characteristics.

Results

Among 149 patients, 23.5 % experienced ETFI-related discontinuation. These patients had significantly lower BMI and shorter feeding durations. Discontinuation was associated with increased unreimbursed medical charges (median JPY +2288/day (USD +15.2/day, USD 1.0 = JPY 150.80) at 1 week post-discontinuation) and decreased living care revenue (median JPY −1179/day (USD −7.82/day)). Multivariate analysis identified ETFI and low BMI (<17.4) as independent predictors of increased hospital revenue losses. Simulations estimated a total loss of JPY 248,000 (USD 1644.56) per 10 hospitalized older patients with GERD over 4 weeks, with greater losses observed in low-BMI patients and those receiving polymeric formulas.

Conclusion

Unplanned discontinuation of enteral tube feeding due to intolerance in older patients with GERD imposes a substantial economic burden on hospitals, primarily through unreimbursed medical charges and reduced living care revenue. Preventive strategies—such as early nutritional intervention and formula selection—may mitigate these losses and support sustainable hospital management.
背景与目的:肠内管喂养不耐受(ETFI)是老年胃食管反流病(GERD)患者的常见并发症,常导致营养支持的计划外中断。虽然ETFI的临床后果有充分的记录,但其对医院业务的经济影响尚不清楚。本研究旨在评估住院老年胃食管反流患者因etfi相关而停止肠内营养的财务后果,重点关注日本混合报销制度下医疗资源分配和医院收入的变化。方法:对2018年4月至2021年3月期间日本一家长期护理病房的患者数据进行回顾性观察性研究。开始肠内管喂养的患者根据肠内喂养是否因不耐受而停止进行分类。对医疗索赔数据进行分析,以计算按服务收费(FFS)和固定支付制度(FPS)收费、未报销的医疗费用(即固定支付制度下的收入损失)和住院生活护理费用。根据停药率和患者特征进行医院损失模拟。结果:149例患者中,23.5%经历了etfi相关停药。这些患者的BMI明显较低,喂养时间也较短。停药后1周,未报销医疗费用增加(中位数为2288日元/天(+15.2美元/天,1.0美元= 150.80日元),生活护理收入减少(中位数为1179日元/天(-7.82美元/天))。多变量分析确定了ETFI和低BMI(结论:老年胃食管反流患者因不耐受而计划外停止肠内管喂养给医院带来了巨大的经济负担,主要是通过未报销的医疗费用和减少的生活护理收入。预防策略,如早期营养干预和配方选择,可以减轻这些损失,并支持可持续的医院管理。
{"title":"Economic consequences when enteral tube feeding intolerance causes unplanned discontinuation in hospitalized older patients with gastroesophageal reflux disease","authors":"Yukikazu Kamada ,&nbsp;Kanako Kawano ,&nbsp;Akina Iguchi ,&nbsp;Noriko Tominaga ,&nbsp;Chisato Okamoto ,&nbsp;Masatoshi Inoue ,&nbsp;Ataru Igarashi ,&nbsp;Masafumi Kitakaze","doi":"10.1016/j.clnesp.2025.102892","DOIUrl":"10.1016/j.clnesp.2025.102892","url":null,"abstract":"<div><h3>Background &amp; aims</h3><div>Enteral tube feeding intolerance (ETFI) is a common complication in older patients with gastroesophageal reflux disease (GERD), often leading to unplanned discontinuation of nutritional support. While the clinical consequences of ETFI are well-documented, its economic impact on hospital operations remains unclear. This study aimed to evaluate the financial consequences of ETFI-related discontinuation of enteral nutrition in hospitalized older patients with GERD, focusing on changes in medical resource allocation and hospital revenue under Japan's hybrid reimbursement system.</div></div><div><h3>Methods</h3><div>A retrospective observational study was conducted using patient-level data from a long-term care ward in Japan between April 2018 and March 2021. Patients who initiated enteral tube feeding were categorized based on whether enteral feeding was discontinued due to intolerance. Medical claims data were analyzed to calculate fee-for-service (FFS) and fixed payment system (FPS) charges, unreimbursed medical charges (i.e., revenue loss under FPS), and inpatient living care expenses. Hospital loss simulations were performed based on discontinuation rates and patient characteristics.</div></div><div><h3>Results</h3><div>Among 149 patients, 23.5 % experienced ETFI-related discontinuation. These patients had significantly lower BMI and shorter feeding durations. Discontinuation was associated with increased unreimbursed medical charges (median JPY +2288/day (USD +15.2/day, USD 1.0 = JPY 150.80) at 1 week post-discontinuation) and decreased living care revenue (median JPY −1179/day (USD −7.82/day)). Multivariate analysis identified ETFI and low BMI (&lt;17.4) as independent predictors of increased hospital revenue losses. Simulations estimated a total loss of JPY 248,000 (USD 1644.56) per 10 hospitalized older patients with GERD over 4 weeks, with greater losses observed in low-BMI patients and those receiving polymeric formulas.</div></div><div><h3>Conclusion</h3><div>Unplanned discontinuation of enteral tube feeding due to intolerance in older patients with GERD imposes a substantial economic burden on hospitals, primarily through unreimbursed medical charges and reduced living care revenue. Preventive strategies—such as early nutritional intervention and formula selection—may mitigate these losses and support sustainable hospital management.</div></div>","PeriodicalId":10352,"journal":{"name":"Clinical nutrition ESPEN","volume":"71 ","pages":"Article 102892"},"PeriodicalIF":2.6,"publicationDate":"2025-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145888750","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Global leadership initiative on malnutrition-based nutritional phenotype and factors associated with the outcomes of hospitalized patients managed by a nutrition support team: A retrospective study 由营养支持小组管理的住院患者基于营养不良的营养表型和与结果相关因素的全球领导倡议:一项回顾性研究。
IF 2.6 Q3 NUTRITION & DIETETICS Pub Date : 2025-12-30 DOI: 10.1016/j.clnesp.2025.102889
Mathilde Barrallier , Emeric Rageul , Charlotte Nesseler , Quentin Le Cornu , Ronan Thibault
<div><h3>Background and aims</h3><div>What are the Global Leadership Initiative on Malnutrition (GLIM) criteria leading to the diagnosis of malnutrition at hospital, specifically in diabetic patients, is not well known. The factors associated with the clinical outcomes of nutritionally at-risk hospitalized patients have been scarcely investigated.</div></div><div><h3>Aims</h3><div>To characterize the GLIM-based nutritional phenotype of hospitalized patients managed by a Nutrition Support Teams (NST) (primary), and to compare the GLIM malnutrition diagnostic criteria between diabetic and non-diabetic patients (secondary); to identify the factors associated with hospital readmission one month after discharge and one-month mortality (secondary).</div></div><div><h3>Methods</h3><div>We conducted a retrospective observational study including all the consecutive adult patients managed by the NST of a tertiary university hospital. The exclusion criteria were age under 18 yr and absence of assessment of body composition by bioimpedance analysis (BIA). Malnutrition was diagnosed according to the GLIM criteria: the etiologic criterion was the hospitalization for an acute or chronic disease, and three phenotypic criteria were: low body mass index (BMI), weight loss, and/or low fat-free mass index (FFMI) derived from BIA. Food intake was assessed by the Simple Evaluation of Food Intake® (SEFI®). Handgrip strength was measured using a dynamometer. Hospital readmission and death one month after discharge were collected from the electronic medical records (EMR). Multivariable logistic regression analyses using a stepwise top-down selection identified factors associated with one-month hospital readmission and mortality.</div></div><div><h3>Results</h3><div>231 patients were included: 43 % of females, age (mean ± SD), 62.2 ± 15.9 yr, BMI, 23.5 ± 6.4, 73.6 % (170/231) were malnourished, of whom 66.5 % (113/170) had severe malnutrition, and 20.3 % (47/231) had diabetes. Malnutrition was diagnosed according to the three phenotypic criteria in 59/170 patients (34.7 %), two in 56/170 patients (33.1 %), and only one in 54/170 patients (31.8 %). The diabetic patients were less likely to have a low FFMI (29.8 % (14/47) vs 60.9 % (109/179), P < 0.001) or be malnourished (61.7 % (29/47) vs 76.6 % (141/184), P = 0.04), but more likely to have a low handgrip strength (64.3 % (27/42) vs 45.6 % (68/149), P = 0.03) than non-diabetic patients. Multivariable analyses showed that cancer (odds ratio (OR) = 2.51 [1.17–5.37], P = 0.02) and SEFI® score (OR = 0.89 [95 % confidence interval, 0.79–0.99], P = 0.04) were associated with higher risk of hospital readmission, whereas weight loss (OR = 3.20 [1.26–8.17], P = 0.01) and diabetes (OR = 2.76 [1.10–6.91], P = 0.03) were associated with mortality.</div></div><div><h3>Conclusion</h3><div>One third of patients were diagnosed malnutrition with one phenotypic criterion, suggesting that all the GLIM phenotypic criteria should be used t
背景和目的:导致医院营养不良诊断的全球营养不良领导倡议(GLIM)标准是什么,特别是糖尿病患者,尚不清楚。与营养不良住院患者临床结果相关的因素很少被调查。目的:表征由营养支持小组(NST)管理的住院患者的基于GLIM的营养表型(主要),并比较糖尿病和非糖尿病患者的GLIM营养不良诊断标准(次要);为了确定与出院后1个月再入院和1个月死亡率(次要)相关的因素,方法:我们进行了一项回顾性观察研究,包括一家三级大学医院NST管理的所有连续成年患者。排除标准为年龄在18岁以下,没有通过生物阻抗分析(BIA)评估身体成分。根据GLIM标准诊断营养不良:病因标准为急性或慢性疾病住院治疗,表型标准为:低体重指数(BMI)、体重减轻和/或低无脂质量指数(FFMI)。通过食物摄入简单评估®(SEFI®)评估食物摄入。用测力仪测量握力。从电子病历(EMR)中收集出院后1个月的再入院和死亡情况。多变量逻辑回归分析采用逐步自上而下的选择确定了与一个月住院再入院和死亡率相关的因素。结果:纳入231例患者:43%的女性,年龄(mean±SD), 62.2±15.9岁,BMI, 23.5±6.4,73.6%(170/231)营养不良,其中66.5%(113/170)为重度营养不良,20.3%(47/231)为糖尿病。3项表型标准诊断为营养不良者59/170(34.7%),2 / 56/170(33.1%),1 / 54/170(31.8%)。糖尿病患者FFMI较低的发生率较低(29.8% (14/47)vs 60.9%(109/179))。结论:1 / 3的患者采用一种表型标准诊断为营养不良,提示应采用所有GLIM表型标准来保证营养不良的诊断。糖尿病患者的FFMI高于非糖尿病患者,握力低于非糖尿病患者。在NST管理的患者中,低食物摄入和癌症与再入院有关,而糖尿病和体重减轻与早期死亡有关。
{"title":"Global leadership initiative on malnutrition-based nutritional phenotype and factors associated with the outcomes of hospitalized patients managed by a nutrition support team: A retrospective study","authors":"Mathilde Barrallier ,&nbsp;Emeric Rageul ,&nbsp;Charlotte Nesseler ,&nbsp;Quentin Le Cornu ,&nbsp;Ronan Thibault","doi":"10.1016/j.clnesp.2025.102889","DOIUrl":"10.1016/j.clnesp.2025.102889","url":null,"abstract":"&lt;div&gt;&lt;h3&gt;Background and aims&lt;/h3&gt;&lt;div&gt;What are the Global Leadership Initiative on Malnutrition (GLIM) criteria leading to the diagnosis of malnutrition at hospital, specifically in diabetic patients, is not well known. The factors associated with the clinical outcomes of nutritionally at-risk hospitalized patients have been scarcely investigated.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Aims&lt;/h3&gt;&lt;div&gt;To characterize the GLIM-based nutritional phenotype of hospitalized patients managed by a Nutrition Support Teams (NST) (primary), and to compare the GLIM malnutrition diagnostic criteria between diabetic and non-diabetic patients (secondary); to identify the factors associated with hospital readmission one month after discharge and one-month mortality (secondary).&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Methods&lt;/h3&gt;&lt;div&gt;We conducted a retrospective observational study including all the consecutive adult patients managed by the NST of a tertiary university hospital. The exclusion criteria were age under 18 yr and absence of assessment of body composition by bioimpedance analysis (BIA). Malnutrition was diagnosed according to the GLIM criteria: the etiologic criterion was the hospitalization for an acute or chronic disease, and three phenotypic criteria were: low body mass index (BMI), weight loss, and/or low fat-free mass index (FFMI) derived from BIA. Food intake was assessed by the Simple Evaluation of Food Intake® (SEFI®). Handgrip strength was measured using a dynamometer. Hospital readmission and death one month after discharge were collected from the electronic medical records (EMR). Multivariable logistic regression analyses using a stepwise top-down selection identified factors associated with one-month hospital readmission and mortality.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Results&lt;/h3&gt;&lt;div&gt;231 patients were included: 43 % of females, age (mean ± SD), 62.2 ± 15.9 yr, BMI, 23.5 ± 6.4, 73.6 % (170/231) were malnourished, of whom 66.5 % (113/170) had severe malnutrition, and 20.3 % (47/231) had diabetes. Malnutrition was diagnosed according to the three phenotypic criteria in 59/170 patients (34.7 %), two in 56/170 patients (33.1 %), and only one in 54/170 patients (31.8 %). The diabetic patients were less likely to have a low FFMI (29.8 % (14/47) vs 60.9 % (109/179), P &lt; 0.001) or be malnourished (61.7 % (29/47) vs 76.6 % (141/184), P = 0.04), but more likely to have a low handgrip strength (64.3 % (27/42) vs 45.6 % (68/149), P = 0.03) than non-diabetic patients. Multivariable analyses showed that cancer (odds ratio (OR) = 2.51 [1.17–5.37], P = 0.02) and SEFI® score (OR = 0.89 [95 % confidence interval, 0.79–0.99], P = 0.04) were associated with higher risk of hospital readmission, whereas weight loss (OR = 3.20 [1.26–8.17], P = 0.01) and diabetes (OR = 2.76 [1.10–6.91], P = 0.03) were associated with mortality.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Conclusion&lt;/h3&gt;&lt;div&gt;One third of patients were diagnosed malnutrition with one phenotypic criterion, suggesting that all the GLIM phenotypic criteria should be used t","PeriodicalId":10352,"journal":{"name":"Clinical nutrition ESPEN","volume":"71 ","pages":"Article 102889"},"PeriodicalIF":2.6,"publicationDate":"2025-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145888788","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Can the 13C-octanoic acid breath test accurately measure gastric emptying after sleeve gastrectomy and Roux-en-Y gastric bypass? A proof-of concept analysis 13c -辛酸呼气试验能准确测量袖式胃切除术和Roux-en-Y胃旁路术后胃排空情况吗?概念验证分析。
IF 2.6 Q3 NUTRITION & DIETETICS Pub Date : 2025-12-29 DOI: 10.1016/j.clnesp.2025.102891
Nele Steenackers , Patrick Augustijns , Wies Deckers , Ellen Deleus , Christophe M. Deroose , Matthias Lannoo , Wei Li , Ann Mertens , Tim Vanuytsel , Greet Vandermeulen , Roman Vangoitsenhoven , Kristin Verbeke , Bart Van der Schueren , Christophe Matthys

Background

Bariatric surgery alters gastrointestinal anatomy and physiology, complicating functional assessments such as gastric emptying. The 13C-octanoic acid breath test is a simple, non-invasive alternative to scintigraphy, though its validity in bariatric populations requires further validation.

Methods

For this proof-of-concept analysis, gastric emptying data were derived from a cross-sectional study including individuals with obesity, sleeve gastrectomy, and Roux-en-Y gastric bypass (RYGB). Gastric emptying was measured simultaneously using the 13C-octanoic breath test and the reference method, scintigraphy. Gastric emptying half-times (GET1/2) were compared between the two methods using Wilcoxon signed-rank tests in each group. Concordance between both methods was assessed using Kendall's tau correlation coefficients, and Bland–Altman plots.

Results

No significant inter-method differences were observed for GET1/2 in any group. Mean differences were −26.7 min (95 % CI: −72.3; 18.6) for obesity, −3.92 min (95 % CI: −30.8; 23.0) for sleeve gastrectomy, and −8.55 min (95 % CI: −21.3; 4.18) for RYGB. Kendall's tau coefficients indicated positive rank associations within each group, but were non-significant (Obesity: 0.8, P = 0.16; sleeve gastrectomy: 0.90, P = 0.13; RYGB: 0.57, P = 0.33). Bland–Altman plots demonstrated acceptable agreement between the measurements across all groups.

Conclusion

This proof-of-concept analysis suggests that the 13C-octanoic acid breath test has potential as a valid, non-invasive method for assessing gastric emptying in post-bariatric surgery patients. However, larger validation studies are warranted to confirm these preliminary findings.
背景:减肥手术改变了胃肠道解剖和生理,使胃排空等功能评估复杂化。13c -辛酸呼吸测试是一种简单、无创的替代方法,但其在肥胖人群中的有效性需要进一步验证。方法:在这个概念验证分析中,胃排空数据来自一项横断面研究,包括肥胖、袖式胃切除术和Roux-en-Y胃旁路(RYGB)患者。采用13c -辛烷酸呼气试验和参考方法-闪烁图同时测量胃排空。采用Wilcoxon符号秩检验比较两种方法的胃排空半衰期(GET1/2)。使用Kendall's tau相关系数和Bland-Altman图评估两种方法之间的一致性。结果:各组间GET1/2无明显差异。肥胖组的平均差异为-26.7分钟(95% CI: -72.3; 18.6),袖胃切除术组的平均差异为-3.92分钟(95% CI: -30.8; 23.0), RYGB组的平均差异为-8.55分钟(95% CI: -21.3; 4.18)。Kendall's tau系数显示各组间的等级正相关,但不显著(肥胖:0.8,P=0.16;袖胃切除术:0.90,P=0.13; RYGB: 0.57, P=0.33)。Bland-Altman图显示了所有组间测量结果的一致性。结论:这一概念验证分析表明,13c -辛酸呼气试验有潜力作为一种有效的、无创的方法来评估减肥手术后患者的胃排空。然而,需要更大规模的验证研究来证实这些初步发现。
{"title":"Can the 13C-octanoic acid breath test accurately measure gastric emptying after sleeve gastrectomy and Roux-en-Y gastric bypass? A proof-of concept analysis","authors":"Nele Steenackers ,&nbsp;Patrick Augustijns ,&nbsp;Wies Deckers ,&nbsp;Ellen Deleus ,&nbsp;Christophe M. Deroose ,&nbsp;Matthias Lannoo ,&nbsp;Wei Li ,&nbsp;Ann Mertens ,&nbsp;Tim Vanuytsel ,&nbsp;Greet Vandermeulen ,&nbsp;Roman Vangoitsenhoven ,&nbsp;Kristin Verbeke ,&nbsp;Bart Van der Schueren ,&nbsp;Christophe Matthys","doi":"10.1016/j.clnesp.2025.102891","DOIUrl":"10.1016/j.clnesp.2025.102891","url":null,"abstract":"<div><h3>Background</h3><div>Bariatric surgery alters gastrointestinal anatomy and physiology, complicating functional assessments such as gastric emptying. The 13C-octanoic acid breath test is a simple, non-invasive alternative to scintigraphy, though its validity in bariatric populations requires further validation.</div></div><div><h3>Methods</h3><div>For this proof-of-concept analysis, gastric emptying data were derived from a cross-sectional study including individuals with obesity, sleeve gastrectomy, and Roux-en-Y gastric bypass (RYGB). Gastric emptying was measured simultaneously using the <sup>13</sup>C-octanoic breath test and the reference method, scintigraphy. Gastric emptying half-times (GET<sub>1/2</sub>) were compared between the two methods using Wilcoxon signed-rank tests in each group. Concordance between both methods was assessed using Kendall's tau correlation coefficients, and Bland–Altman plots.</div></div><div><h3>Results</h3><div>No significant inter-method differences were observed for GET<sub>1/2</sub> in any group. Mean differences were −26.7 min (95 % CI: −72.3; 18.6) for obesity, −3.92 min (95 % CI: −30.8; 23.0) for sleeve gastrectomy, and −8.55 min (95 % CI: −21.3; 4.18) for RYGB. Kendall's tau coefficients indicated positive rank associations within each group, but were non-significant (Obesity: 0.8, <em>P</em> = 0.16; sleeve gastrectomy: 0.90, <em>P</em> = 0.13; RYGB: 0.57, <em>P</em> = 0.33). Bland–Altman plots demonstrated acceptable agreement between the measurements across all groups.</div></div><div><h3>Conclusion</h3><div>This proof-of-concept analysis suggests that the 13C-octanoic acid breath test has potential as a valid, non-invasive method for assessing gastric emptying in post-bariatric surgery patients. However, larger validation studies are warranted to confirm these preliminary findings.</div></div>","PeriodicalId":10352,"journal":{"name":"Clinical nutrition ESPEN","volume":"71 ","pages":"Article 102891"},"PeriodicalIF":2.6,"publicationDate":"2025-12-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145877834","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Body composition and functional status in the COVID-19 recovery phase: Prevalence of sarcopenia and sarcopenic obesity COVID-19恢复期的身体成分和功能状态:肌肉减少症和肌肉减少性肥胖的患病率
IF 2.6 Q3 NUTRITION & DIETETICS Pub Date : 2025-12-29 DOI: 10.1016/j.clnesp.2025.102877
Montserrat Montes-Ibarra , Flavio T. Vieira , Maria Cristina Gonzalez , Alan Garcia-Grimaldo , Ivan Armando Osuna-Padilla , Andreia Bauermann-Vieira , Edith Pituskin , Richard B. Thompson , D. Ian Paterson , Carla M. Prado

Background & aims

COVID-19 may be associated with unfavourable body composition changes. This includes increased fat mass and decreased muscle mass, which can lead to sarcopenia and sarcopenic obesity (SO), conditions associated with impaired physical performance and reduced quality of life, among other adverse outcomes. This study investigated the prevalence of sarcopenia and SO in individuals who recovered from the first COVID-19 wave and their association with functional outcomes.

Methods

Clinical characteristics, body composition (bioelectrical impedance analysis), functional status (handgrip strength [HGS], 6-min walk test [6MWT]), and lung function (spirometry) were collected.

Results

37 individuals (89.2 % Caucasians, 64.9 % females, median age 48 years [IQR: 40; 60], 10.8 % > 65y) were assessed after a median of 189 days (IQR: 169; 201) post-COVID-19 infection. The combined prevalence of sarcopenia/SO was 40.5 %, was identified in 37.8 %, while a single case (2.7 %) of sarcopenia without obesity was found. The sarcopenia/SO group had lower 6MWT and phase angle, and higher prevalence of hypertension. Sarcopenia/SO was negatively associated with 6MWT performance (β: −115.35, 95 % CI: −161.57 to −69.12), COVID-19 symptoms, disease severity, and duration were not associated with sarcopenia/SO diagnosis.

Conclusion

A high presence of sarcopenia/SO was identified and was negatively associated with health outcomes in individuals post-COVID-19. Thus, it is important to assess and address conditions associated with abnormal body composition after infectious diseases to better inform strategies for improving long-term outcomes.
背景与目的:COVID-19可能与不利的身体组成变化有关。这包括脂肪量增加和肌肉量减少,这可能导致肌肉减少症和肌肉减少性肥胖(SO),以及与身体机能受损和生活质量下降相关的疾病,以及其他不良后果。本研究调查了从第一次COVID-19浪潮中恢复的个体中肌肉减少症和SO的患病率及其与功能结局的关系。方法:收集患者的临床特征、身体组成(生物电阻抗分析)、功能状态(握力[HGS]、6分钟步行试验[6MWT])、肺功能(肺活量测定)。结果:37例患者(89.2%为白种人,64.9%为女性,中位年龄为48岁[IQR: 40; 60], 10.8%为bb0 - 65岁)在感染后189天(IQR: 169; 201)后接受评估。骨骼肌减少症/SO的总患病率为40.5%,其中37.8%被确诊为骨骼肌减少症,而未发现肥胖的骨骼肌减少症单一病例(2.7%)。肌少症/SO组6MWT和相位角较低,高血压患病率较高。肌少症/SO与6MWT表现呈负相关(β: -115.35, 95% CI: -161.57至-69.12),COVID-19症状、疾病严重程度和持续时间与肌少症/SO诊断无关。结论:在covid -19后个体中,肌肉减少症/SO的存在率很高,并且与健康结果呈负相关。因此,重要的是评估和解决传染病后与异常身体成分相关的条件,以更好地为改善长期结果的策略提供信息。
{"title":"Body composition and functional status in the COVID-19 recovery phase: Prevalence of sarcopenia and sarcopenic obesity","authors":"Montserrat Montes-Ibarra ,&nbsp;Flavio T. Vieira ,&nbsp;Maria Cristina Gonzalez ,&nbsp;Alan Garcia-Grimaldo ,&nbsp;Ivan Armando Osuna-Padilla ,&nbsp;Andreia Bauermann-Vieira ,&nbsp;Edith Pituskin ,&nbsp;Richard B. Thompson ,&nbsp;D. Ian Paterson ,&nbsp;Carla M. Prado","doi":"10.1016/j.clnesp.2025.102877","DOIUrl":"10.1016/j.clnesp.2025.102877","url":null,"abstract":"<div><h3>Background &amp; aims</h3><div>COVID-19 may be associated with unfavourable body composition changes. This includes increased fat mass and decreased muscle mass, which can lead to sarcopenia and sarcopenic obesity (SO), conditions associated with impaired physical performance and reduced quality of life, among other adverse outcomes. This study investigated the prevalence of sarcopenia and SO in individuals who recovered from the first COVID-19 wave and their association with functional outcomes.</div></div><div><h3>Methods</h3><div>Clinical characteristics, body composition (bioelectrical impedance analysis), functional status (handgrip strength [HGS], 6-min walk test [6MWT]), and lung function (spirometry) were collected.</div></div><div><h3>Results</h3><div>37 individuals (89.2 % Caucasians, 64.9 % females, median age 48 years [IQR: 40; 60], 10.8 % &gt; 65y) were assessed after a median of 189 days (IQR: 169; 201) post-COVID-19 infection. The combined prevalence of sarcopenia/SO was 40.5 %, was identified in 37.8 %, while a single case (2.7 %) of sarcopenia without obesity was found. The sarcopenia/SO group had lower 6MWT and phase angle, and higher prevalence of hypertension. Sarcopenia/SO was negatively associated with 6MWT performance (β: −115.35, 95 % CI: −161.57 to −69.12), COVID-19 symptoms, disease severity, and duration were not associated with sarcopenia/SO diagnosis.</div></div><div><h3>Conclusion</h3><div>A high presence of sarcopenia/SO was identified and was negatively associated with health outcomes in individuals post-COVID-19. Thus, it is important to assess and address conditions associated with abnormal body composition after infectious diseases to better inform strategies for improving long-term outcomes.</div></div>","PeriodicalId":10352,"journal":{"name":"Clinical nutrition ESPEN","volume":"72 ","pages":"Article 102877"},"PeriodicalIF":2.6,"publicationDate":"2025-12-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145877796","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The effect of transcranial direct current stimulation and nutritional counseling therapy on attentional bias to food cues: A randomized clinical trial 经颅直流电刺激和营养咨询治疗对食物线索注意偏倚的影响:一项随机临床试验。
IF 2.6 Q3 NUTRITION & DIETETICS Pub Date : 2025-12-26 DOI: 10.1016/j.clnesp.2025.102886
Jessica Lorenzzi Elkfury , Luciana C. Antunes , Gibson Weydmann , Lizia Nardi Menegassi , Liciane Fernandes Medeiros , Tiago Madeira Cardinal , Betina Franceschini Tocchetto , Iraci L.S. Torres , Felipe Fregni , Lisiane Bizarro , Wolnei Caumo

Background & aims

This study investigated the effects of transcranial direct current stimulation (tDCS) and nutritional counseling therapy (NCT) on attentional bias (AB) in binge eating disorder.

Methods

This study was designed as a pilot randomized, factorial, blind, parallel-controlled clinical trial. Forty women were allocated to one of four groups: active tDCS (a-tDCS), a-tDCS + NCT, s-tDCS (sham tDCS) + NCT, NCT. The 28 home-based tDCS sessions were applied to the DLPFC (anode/right and cathode/left). The outcome was the delta values (pre- and post-treatment AB scores). Each AB score was calculated based on the stimulus onset asynchrony (SOA) at which stimuli were presented (100, 500, and 2000 ms).

Results

Mixed analyses of variance revealed a significant interaction between treatment and SOA (p = 0.035). The a-tDCS with NCT group showed a decrease in AB at an SOA of 500 ms. This decrease significantly differed from the increase observed in the s-tDCS with NCT group for the same SOA (p = 0.027). The a-tDCS with NCT group showed an increase in AB at an SOA of 2000 ms, which differed significantly from the decrease observed at the same SOA in the a-tDCS group (p = 0.032).

Conclusions

The combined therapy (a-tDCS with NCT) decreased AB at the pre-conscious orientation of attention and increased it when conscious orientation was possible.

Trial registration

ClinicalTrials.gov: NCT 04226794. Registered on July 2, 2019.
背景与目的:本研究探讨经颅直流电刺激(tDCS)和营养咨询治疗(NCT)对暴食症患者注意偏置(AB)的影响。方法:本研究采用随机、盲法、平行对照临床试验。40名女性被分为四组:活动tDCS (a-tDCS)、a-tDCS + NCT、s-tDCS(假tDCS) + NCT、NCT。28个基于家庭的tDCS会话应用于DLPFC(阳极/右和阴极/左)。结果是δ值(治疗前和治疗后的AB评分)。每个AB分数是根据刺激出现时(100ms、500ms和2000ms)的刺激发生异步性(SOA)来计算的。结果:混合方差分析显示治疗与SOA之间有显著的相互作用(p = 0.035)。a- tdcs加NCT组在SOA 500 ms时AB下降。这种下降明显不同于s-tDCS与NCT组在相同SOA下观察到的增加(p = 0.027)。具有NCT的a-tDCS组在SOA为2000 ms时AB增加,这与a-tDCS组在相同SOA下观察到的AB减少有显著差异(p = 0.032)。结论:a-tDCS与NCT联合治疗可降低注意前意识取向时的AB值,并可使注意前意识取向时AB值升高。试验注册:ClinicalTrials.gov: NCT04226794。2019年7月2日注册。
{"title":"The effect of transcranial direct current stimulation and nutritional counseling therapy on attentional bias to food cues: A randomized clinical trial","authors":"Jessica Lorenzzi Elkfury ,&nbsp;Luciana C. Antunes ,&nbsp;Gibson Weydmann ,&nbsp;Lizia Nardi Menegassi ,&nbsp;Liciane Fernandes Medeiros ,&nbsp;Tiago Madeira Cardinal ,&nbsp;Betina Franceschini Tocchetto ,&nbsp;Iraci L.S. Torres ,&nbsp;Felipe Fregni ,&nbsp;Lisiane Bizarro ,&nbsp;Wolnei Caumo","doi":"10.1016/j.clnesp.2025.102886","DOIUrl":"10.1016/j.clnesp.2025.102886","url":null,"abstract":"<div><h3>Background &amp; aims</h3><div>This study investigated the effects of transcranial direct current stimulation (tDCS) and nutritional counseling therapy (NCT) on attentional bias (AB) in binge eating disorder.</div></div><div><h3>Methods</h3><div>This study was designed as a pilot randomized, factorial, blind, parallel-controlled clinical trial. Forty women were allocated to one of four groups: active tDCS (a-tDCS), a-tDCS + NCT, s-tDCS (sham tDCS) + NCT, NCT. The 28 home-based tDCS sessions were applied to the DLPFC (anode/right and cathode/left). The outcome was the delta values (pre- and post-treatment AB scores). Each AB score was calculated based on the stimulus onset asynchrony (SOA) at which stimuli were presented (100, 500, and 2000 ms).</div></div><div><h3>Results</h3><div>Mixed analyses of variance revealed a significant interaction between treatment and SOA (p = 0.035). The a-tDCS with NCT group showed a decrease in AB at an SOA of 500 ms. This decrease significantly differed from the increase observed in the s-tDCS with NCT group for the same SOA (p = 0.027). The a-tDCS with NCT group showed an increase in AB at an SOA of 2000 ms, which differed significantly from the decrease observed at the same SOA in the a-tDCS group (p = 0.032).</div></div><div><h3>Conclusions</h3><div>The combined therapy (a-tDCS with NCT) decreased AB at the pre-conscious orientation of attention and increased it when conscious orientation was possible.</div></div><div><h3>Trial registration</h3><div>ClinicalTrials.gov: NCT 04226794. Registered on July 2, 2019.</div></div>","PeriodicalId":10352,"journal":{"name":"Clinical nutrition ESPEN","volume":"72 ","pages":"Article 102886"},"PeriodicalIF":2.6,"publicationDate":"2025-12-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145849100","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Clinical nutrition ESPEN
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1